Skip to main content

ADVERTISEMENT

Susan M. O'Brien, MD

Susan M. O'Brien, MD
Videos
08/16/2023
At the 2023 EHA meeting in Frankfurt, Germany, Susan M. O'Brien, MD, provided insights into the latest frontline therapeutic options for patients with chronic lymphocytic leukemia.
At the 2023 EHA meeting in Frankfurt, Germany, Susan M. O'Brien, MD, provided insights into the latest frontline therapeutic options for patients with chronic lymphocytic leukemia.
At the 2023 EHA meeting in...
08/16/2023
Oncology
Susan M. O'Brien, MD
Videos
08/17/2023
Susan M. O'Brien, MD, discusses the possible applications of pirtobrutinib, a noncovalent BTK inhibitor, for the treatment of patients with CLL.
Susan M. O'Brien, MD, discusses the possible applications of pirtobrutinib, a noncovalent BTK inhibitor, for the treatment of patients with CLL.
Susan M. O'Brien, MD, discusses...
08/17/2023
Oncology